Skip to main content
Year archive

PARATAXIS KOREA, INC. — 2020 filings

All 63 regulatory filings released by PARATAXIS KOREA, INC. (288330) in 2020, sourced directly from the official regulator.

63 Filings
2020 Period
2020 filings (63)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-12-08 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-12-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-12-07 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-11-12 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-11-10 Korean
투자판단관련주요경영사항(베링거인겔하임, 특발성 폐섬유증 신약 BBT-877 독점 권리 반환의 건)
M&A Activity
2020-11-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-11-03 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-11-03 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-10-30 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-10-07 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-10-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-09-25 Korean
권리락(무상증자)
Share Issue/Capital Change
2020-09-21 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-09-15 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2020-09-08 Korean
주권매매거래정지(무상증자)
Delisting Announcement
2020-09-08 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2020-09-08 Korean
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update
2020-09-03 Korean
[기재정정]기업설명회(IR)개최
Report Publication Announcement
2020-08-18 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-14 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-08-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-06-11 Korean
[기재정정]사업보고서 (2019.12)
Regulatory Filings FY 2019
2020-06-11 Korean
기업설명회(IR)개최
Investor Presentation
2020-05-28 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-14 Korean
기업설명회(IR)개최
Regulatory Filings Q2 2020
2020-05-12 Korean
투자판단관련주요경영사항(폐암 EGFR-TKI 제제 BBT-176 한국 식약처 임상 1/2상 시험계획 승인)
Regulatory Filings
2020-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-13 Korean
기업설명회(IR)개최
Investor Presentation
2020-04-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-30 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-27 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update
2020-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-11 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-11 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-11 Korean
의결권대리행사권유참고서류
AGM Information
2020-03-06 Korean
주주총회소집공고
AGM Information
2020-03-05 Korean
[기재정정]기업설명회(IR)개최
Investor Presentation
2020-03-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-05 Korean
주식매수선택권행사
Share Issue/Capital Change
2020-03-02 Korean
단일판매ㆍ공급계약체결
M&A Activity
2020-03-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-20 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-02-19 Korean
기업설명회(IR)개최
Investor Presentation
2020-02-19 Korean
투자판단관련주요경영사항(안저질환 치료제 후보물질 기술도입 및 공동연구계약 체결)
Capital/Financing Update
2020-02-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-03 Korean
투자판단관련주요경영사항(폐암 EFGR-TKI 제재 BBT-176 미국 FDA 임상 1/2상 시험계획 승인)
Regulatory Filings
2020-01-20 Korean